Santa Casa de Misericórdia de Belo Horizonte

Belo Horizonte MG30150-221

1 studies enrolling now · 8 studies all time

What they study most

Coronavirus Disease 2019, Gout, Gout Flare, Hyperuricemia, Lupus Erythematosus, Systemic, Partial Epilepsy, Proteinuric Kidney Disease, Septic Shock, Systemic Lupus Erythematosus, Tophi, Vasodilatory Shock

Studies at this site

• Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease — Recruiting now
• The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE) — Running, not enrolling
• The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW) — Completed
• Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients — Completed
• A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus — Completed
• Study of M5049 in Participants With COVID-19 Pneumonia (ANEMONE) — Completed
• Heparin Anticoagulation in Septic Shock — Stopped early
• Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures — Completed